Poly-therapy with EGFR, STAT3 and Src-YAP1 signaling...

Annals of Oncology 2016 / 10 Vol. 27; Iss. suppl_6

Poly-therapy with EGFR, STAT3 and Src-YAP1 signaling pathway inhibition; A breakthrough for EGFR mutant NSCLC

Karachaliou, N., Chaib, I., Cai, X., Li, X., Cardona, A.F., López-Vivanco, G., Vergnenegre, A., Torres, J.M. Sanchez, Provencio, M., de Marinis, F., Carecereny, E., Reguart, N., Campelo, R. García, Vi
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
27
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdw382.02
Date:
October, 2016
File:
PDF, 69 KB
2016
Conversion to is in progress
Conversion to is failed